Use of parasternal intercostal plane block ropivacaine in reduce hemodynamic fluctuations during elective cardiac surgery

Role of parasternal intercostal plane block using ropivacaine in attenuating hemodynamic fluctuations at the time of sternotomy in patients undergoing elective cardiac surgery - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073274

Enrollment

Registered

2024-09-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery

Interventions

Intervention1: Parasternal intercostal plane block with 0.5% ropivacaine under ultrasound guidance before sternotomy: The intervention group will receive a parasternal intercostal plane block with 0.5

Eligibility

Inclusion criteria

Inclusion criteria: Patients =18 years and =60 years posted for elective cardiac surgery.

Exclusion criteria

Exclusion criteria: Patients with - Patient giving history of past cardiac surgery using sternotomy or needing end of life care support. - Coronary Artery Disease (CABG will be excluded). - Uncontrolled Diabetes Mellitus type – 2 (HbA1C =9). - Chronic Kidney Disease. - Documented Liver dysfunction (CHILD’s Class B, C)

Design outcomes

Primary

Measure	Time frame
The primary outcome measure will be the magnitude of hemodynamic fluctuations, defined as the percentage change in mean arterial pressure from baseline to intraoperative measurements.Timepoint: 12 month	—

Secondary

Measure	Time frame
Secondary outcome measures will include changes in heart rate, systolic blood pressure, diastolic blood pressure, central venous pressure, duration of mechanical ventilation, length of intensive care unit (ICU) stay, postoperative pain scores, and adverse events. Timepoint: 1hrs to 24hrs	—

Countries

India

Contacts

Public ContactProf Dinesh Singh

King Georges Medical University Lucknow

dineshkgmu@gmail.com9415022330

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026